|Title:||2019 consensus of the Taiwan hypertension society and Taiwan society of cardiology on the clinical application of central blood pressure in the management of hypertension||Authors:||Chuang, Shao Yuan
Chen, Chen Huan
Sung, Shih Hsien
Wang, Jiun Jr
Cheng, Hao Min
Hsu, Pai Feng
|Keywords:||Brachial BP | Central BP | Diagnosis | High BP | Hypertension | Management | Peripheral BP||Issue Date:||1-May-2019||Journal Volume:||35||Journal Issue:||3||Source:||Acta Cardiologica Sinica||Abstract:||
© 2019, Republic of China Society of Cardiology. All rights reserved. The Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) have appointed a joint consensus group for the 2019 Consensus of the TSOC and THS on the Clinical Application of Central blood pressure (BP) in the Management of Hypertension with the aim of formulating a management consensus on the clinical application of central BP in the management of hypertension. This consensus document focuses on the clinical application of central BP in the care of patients with hypertension. The major determinants of central BP are increased arterial stiffness and wave reflection, which are also the dominant hemodynamicmanifestations of vascular aging. Central BP can bemeasured noninvasively using various techniques, including with convenient cuff-based oscillometric central BP monitors. Noninvasive central BP is better than conventional brachial BP to assess target organ damage and long-term cardiovascular outcomes. Based on the analysis of long-term events, a central BP threshold of 130/90 mmHg for defining hypertension has been proposed. Recent studies have suggested that a central BP strategy to confirm a diagnosis of hypertension may be more cost-effective than conventional strategies, and that guiding hypertensionmanagement with central BP may result in the use of fewer medications to achieve BP control. Although noninvasive measurements of brachial BP are inaccurate and central BP has been shown to carry superior prognostic value beyond brachial BP, the use of central BP should be justified in studies comparing central BP-guided therapeutic strategies with conventional care for cardiovascular events.
|Appears in Collections:||醫學院附設醫院 (臺大醫院)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.